MedTrace Logo

Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy

NCT05526703 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2022-11-28

No results posted yet for this study

Summary

Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy.

Conditions

  • Essential Hypertension

Interventions

DRUG

D064, D701, placebo of D012

Experimental Group Subjects assigned to this group are treated with D064, D701, placebo of D012

DRUG

D012, placebo of D064, placebo of D701

Comparator Group Subjects assigned to this group are treated with D012, placebo of D064, placebo of D701

Sponsors & Collaborators

  • Chong Kun Dang Pharmaceutical

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-28
Primary Completion
2023-10-31
Completion
2023-10-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05526703 on ClinicalTrials.gov